Sign in

CIK 0001604821

  • Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010894487
Phone
+1 650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$104,832,418
in 28 filings, $104.8M under 10b5-1 plans

Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-10-25 Baynes Roy D. Director Grant or award +124 15,807
2024-10-25 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −691 $118.81 $82K 72,709
2024-10-24 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −914 $119.19 $109K 73,400
2024-10-23 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −496 $119.09 $59K 74,314
2024-10-22 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale 10b5-1 −256 $120.07 $31K 111,891
2024-10-22 Fesko John PRESIDENT, CHIEF BUS. OFFICER Sale 10b5-1 −199 $120.07 $24K 114,065
2024-10-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +1,250 74,810
2024-10-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −1,250 5,000
2024-10-22 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sale 10b5-1 −349 $120.07 $42K 207,084
2024-10-22 Chapman Steven Leonard CEO AND PRESIDENT Sale 10b5-1 −893 $120.07 $107K 193,722
2024-10-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −454 $120.07 $55K 73,560
2024-10-21 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale 10b5-1 −294 $120.76 $36K 112,147
2024-10-21 Fesko John PRESIDENT, CHIEF BUS. OFFICER Sale 10b5-1 −342 $120.76 $41K 114,264
2024-10-21 Sheena Jonathan Director Exercise or conversion 10b5-1 +143 282,374
2024-10-21 Sheena Jonathan Director Exercise or conversion · Restricted Stock Unit 10b5-1 −143 144
2024-10-21 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Exercise or conversion 10b5-1 +644 207,900
2024-10-21 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sale 10b5-1 −467 $120.76 $56K 207,433
2024-10-21 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −644 644
2024-10-21 Chapman Steven Leonard CEO AND PRESIDENT Exercise or conversion 10b5-1 +1,775 196,324
2024-10-21 Chapman Steven Leonard CEO AND PRESIDENT Sale 10b5-1 −1,709 $120.76 $206K 194,615

Page 65 of 85 · 1,682 trades